Retreatment with Pegloticase after a Gap in Therapy in Patients with Gout: A Report of Four Cases
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Morton, Allan H.
Funding for this research was provided by:
Horizon Pharma USA, Inc.
26 March 2018
3 May 2018